S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:HARP

Harpoon Therapeutics Insider Trades

$6.61
-0.44 (-6.24%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.49
$7.10
50-Day Range
$6.12
$8.45
52-Week Range
$5.80
$25.24
Volume
225,244 shs
Average Volume
353,192 shs
Market Capitalization
$216.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.73

Harpoon Therapeutics (NASDAQ:HARP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.40%

Number Of
Insiders Buying
(Last 12 Months)
1

Amount Of
Insider Buying
(Last 12 Months)
$83.43 K

Number Of
Insiders Selling
(Last 12 Months)
4

Amount Of
Insider Selling
(Last 12 Months)
$36.66 M

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get HARP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Harpoon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Harpoon Therapeutics (NASDAQ HARP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/22/2021Georgia ErbezCFOBuy10,300$8.10$83,430.00  
7/1/2021Holger WescheInsiderSell10,000$14.00$140,000.0062,852  
6/1/2021Ansbert GadickeMajor ShareholderSell18,491$20.44$377,956.04  
5/28/2021Ansbert GadickeMajor ShareholderSell13,885$21.12$293,251.20  
5/26/2021Ansbert GadickeMajor ShareholderSell3,198$20.04$64,087.92  
5/24/2021Ansbert GadickeMajor ShareholderSell5,000$20.12$100,600.00  
5/21/2021Ansbert GadickeMajor ShareholderSell10,907$20.21$220,430.47  
5/19/2021Ansbert GadickeMajor ShareholderSell17,833$20.39$363,614.87  
5/17/2021Ansbert GadickeMajor ShareholderSell4,666$20.07$93,646.62  
5/14/2021Ansbert GadickeMajor ShareholderSell6,900$20.04$138,276.00  
5/12/2021Ansbert GadickeMajor ShareholderSell29,684$20.53$609,412.52  
5/10/2021Ansbert GadickeMajor ShareholderSell17,133$21.80$373,499.40  
5/4/2021Impact Fund (Cayman) OncologyMajor ShareholderSell328,519$22.48$7,385,107.12  
4/29/2021Impact Fund (Cayman) OncologyMajor ShareholderSell130,143$21.99$2,861,844.57  
4/21/2021Ansbert GadickeMajor ShareholderSell8,972$18.97$170,198.84  
4/19/2021Ansbert GadickeMajor ShareholderSell10,056$19.30$194,080.80  
4/16/2021Ansbert GadickeMajor ShareholderSell5,847$19.86$116,121.42  
4/14/2021Bioventures 2014 L.P. MpmMajor ShareholderSell1,671$20.77$34,706.67  
4/12/2021Ansbert GadickeMajor ShareholderSell20,628$21.02$433,600.56  
4/9/2021Ansbert GadickeMajor ShareholderSell10,300$23.67$243,801.00  
4/1/2021Holger WescheInsiderSell10,000$20.45$204,500.0061,318  
2/10/2021Bioventures 2014 L.P. MpmMajor ShareholderSell183,051$20.00$3,661,020.00  
2/8/2021Bioventures 2014 L.P. MpmMajor ShareholderSell72,128$20.04$1,445,445.12  
2/4/2021Bioventures 2014 L.P. MpmMajor ShareholderSell29,730$20.37$605,600.10  
2/2/2021Bioventures 2014 L.P. MpmMajor ShareholderSell48,421$20.13$974,714.73  
1/27/2021Bioventures 2014 L.P. MpmMajor ShareholderSell706,825$20.00$14,136,500.00  
1/25/2021Bioventures 2014 L.P. MpmMajor ShareholderSell13,006$21.23$276,117.38  
1/22/2021Bioventures 2014 L.P. MpmMajor ShareholderSell24,695$21.72$536,375.40  
1/20/2021Bioventures 2014 L.P. MpmMajor ShareholderSell17,694$24.04$425,363.76  
1/4/2021Holger WescheInsiderSell10,000$18.38$183,800.00  
8/18/2020Georgia ErbezCFOBuy2,098$11.60$24,336.8047,292  
7/31/2020Georgia ErbezCFOBuy1,817$10.92$19,841.6447,292  
7/1/2020Holger WescheInsiderSell10,000$16.20$162,000.0062,669  
5/27/2020Bioscience Plc ArixMajor ShareholderSell12,064$22.39$270,112.96  
5/18/2020Natalie SacksInsiderSell1,522$14.77$22,479.9447,276  
5/11/2020Holger WescheInsiderSell1,000$14.07$14,070.0058,019  
5/8/2020Holger WescheInsiderSell1,000$14.00$14,000.0058,019  
5/1/2020Natalie SacksInsiderSell5,826$12.07$70,319.8251,580  
4/28/2020Holger WescheInsiderSell1,250$14.05$17,562.5053,919  
4/17/2020Natalie SacksInsiderSell1,021$12.08$12,333.6846,254  
4/13/2020Natalie SacksInsiderSell4,556$12.06$54,945.3650,310  
4/6/2020Natalie SacksInsiderSell700$12.00$8,400.0046,454  
3/2/2020Natalie SacksInsiderSell5,826$14.68$85,525.6851,580  
2/3/2020Natalie SacksInsiderSell5,826$13.90$80,981.4051,580  
1/21/2020Georgia ErbezCFOBuy6,700$14.09$94,403.0047,292  
1/16/2020Natalie SacksInsiderSell1,521$14.94$22,723.7447,275  
1/2/2020Holger WescheInsiderSell10,000$14.40$144,000.0062,669  
12/27/2019Patrick BaeuerleDirectorSell87,379$15.98$1,396,316.42  
12/17/2019Mark ChinDirectorSell12,476$16.83$209,971.08  
12/16/2019Bioscience Plc ArixMajor ShareholderSell13,080$17.02$222,621.60  
12/16/2019Natalie SacksInsiderSell1,521$17.02$25,887.4247,275  
12/13/2019Bioscience Plc ArixMajor ShareholderSell11,002$17.21$189,344.42  
12/10/2019Bioscience Plc ArixMajor ShareholderSell131,696$16.91$2,226,979.36  
12/9/2019Mark ChinDirectorSell103,754$18.16$1,884,172.64  
12/6/2019Mark ChinDirectorSell47,752$19.15$914,450.80  
12/2/2019Natalie SacksInsiderSell5,826$17.98$104,751.4851,580  
11/18/2019Natalie SacksInsiderSell18,252$14.34$261,733.68
11/1/2019Natalie SacksInsiderSell5,826$13.74$80,049.24
10/15/2019Natalie SacksInsiderSell24,150$13.51$326,266.50
5/14/2019Gerald Phd McmahonInsiderBuy1,000$10.16$10,160.00  
5/8/2019Gerald Phd McmahonInsiderBuy1,000$10.56$10,560.00  
5/3/2019Gerald Phd McmahonInsiderBuy1,000$10.53$10,530.00  
2/12/2019Bioscience Plc ArixMajor ShareholderBuy428,571$14.00$5,999,994.00  
2/12/2019Luke EvninDirectorBuy250,000$14.00$3,500,000.00  
(Data available from 1/1/2013 forward)












Harpoon Therapeutics (NASDAQ:HARP) Insider Trade Frequently Asked Questions

Who is on Harpoon Therapeutics's Insider Roster?

The list of insiders at Harpoon Therapeutics includes Ansbert Gadicke, Bioscience Plc Arix, Bioventures 2014 L.P. Mpm, Georgia Erbez, Gerald Phd Mcmahon, Holger Wesche, Impact Fund (Cayman) Oncology, Luke Evnin, Mark Chin, Natalie Sacks, and Patrick Baeuerle.Learn more on HARP's insiders

What percentage of Harpoon Therapeutics stock is owned by insiders?

4.40% of Harpoon Therapeutics stock is owned by insiders. Learn more on HARP's insider holdings

Which Harpoon Therapeutics insiders have been buying company stock?

The following insider purchased Harpoon Therapeutics stock in the last 24 months: Georgia Erbez ($222,011.44).

How much insider buying is happening at Harpoon Therapeutics?

Insiders have purchased a total of 20,915 Harpoon Therapeutics shares in the last 24 months for a total of $222,011.44 bought.

Which Harpoon Therapeutics insiders have been selling company stock?

The following insiders have sold Harpoon Therapeutics stock in the last 24 months: Ansbert Gadicke ($3,792,577.66), Bioscience Plc Arix ($2,909,058.34), Bioventures 2014 L.P. Mpm ($22,095,843.16), Holger Wesche ($879,932.50), Impact Fund (Cayman) Oncology ($10,246,951.69), Mark Chin ($3,008,594.52), Natalie Sacks ($488,348.52), and Patrick Baeuerle ($1,396,316.42).

How much insider selling is happening at Harpoon Therapeutics?

Insiders have sold a total of 2,245,981 Harpoon Therapeutics shares in the last 24 months for a total of $44,817,622.81 sold.

This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.